Food and Drug Administration has granted conditional approval to Vivitrol, a once-a-month, naltrexone-based drug intended to curb craving for alcohol, Reuters reported Dec. 29. -- The injectable drug, developed by Alkermes, Inc., is expected to hit the market in 2006. The company still has...